BioWorld

Sep. 26, 2006

View Archived Issues

GPC Biotech Shares Jump On Prostate Cancer Study Results

Read More

House Committee Passes Bill For Biodefense Agency

Read More

NovaCardia Series B Raises $48M For Phase III CHF Bid

Read More

Other News To Note

Read More

Clinic Roundup

Read More

Fampridine-SR Data Sends Acorda Stock Through Roof

Shares in Acorda Therapeutics Inc. rocketed by more than 282 percent Monday on positive findings from a Phase III study of Fampridine-SR in multiple sclerosis. (BioWorld Today) Read More

BIO Midwest Event Brings Biotech, VCs To Cleveland

Read More